NASDAQ : CLPT

ClearPoint Neuro, Inc. — Institutional Ownership

$14.13 USD

$0.74 (5.53%)

Volume
326.14K
Average Volume
702.82K
Market Capitalization
$423.75M
P/E Ratio
-11.97
Dividend Yield
0.00%
Price Target
$23.50
Year High
$30.10
Year Low
$8.27
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$4.73
Institutional Ownership Summary
Institutional Ownership %

6.48%

Investors Holding

41

change: -84.0 | last: 125
Increased Positions

23

change: -51.0 | last: 74
Reduced Positions

7

change: -14.0 | last: 21
New Positions

10

change: -19.0 | last: 29
Sold Positions

90

change: 63.0 | last: 27
Total Calls

-

Total Puts

-

Put-Call Ratio

0.00

change: -55.0759 | last: 0.5508
Total Invested

34.14M

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-05-15 MAK Capital Fund LP 1.9M 6.30%
2026-04-20 BIGGER CAPITAL FUND L P 1.36M 4.54%
2026-03-26 The Vanguard Group - 0.00%
2026-03-13 MAK Capital Fund LP 1.73M 6.10%
2026-02-04 BIGGER CAPITAL FUND L P 1.33M 4.69%
2025-11-12 BIGGER CAPITAL FUND L P 1.29M 4.55%
2025-08-04 BIGGER CAPITAL FUND L P 1.17M 4.20%
2025-07-29 The Vanguard Group 1.48M 5.27%
2025-07-17 BlackRock, Inc. 1.58M 5.60%
2025-05-09 BIGGER CAPITAL FUND L P 1.13M 4.00%
2025-01-29 BIGGER CAPITAL FUND L P 1.11M 4.00%
2024-02-13 The Vanguard Group - 23-1945930 1.31M 5.32%
2024-01-29 (1) BlackRock, Inc. 1.47M 6.00%
2021-06-09 Bigger Capital Fund, LP 575.48K 2.80%
2021-03-02 PTC Therapeutics, Inc. 2.96M 14.00%
2021-02-11 Thomas A. Satterfield, Jr. 720K 4.00%
2020-02-13 Thomas A. Satterfield, Jr. 1.22M 7.80%
2020-01-31 PTC Therapeutics, Inc. 2.96M 17.27%
2019-05-24 PTC Therapeutics, Inc. 1.29M 9.56%
2018-02-09 E. Jeffrey Peierls(1) 690K 9.99%
2018-02-05 Mellon Group, LLC 587.6K 5.60%
2018-01-12 Page 1 of 5 600K 5.80%
2017-10-04 only). 506.62K 4.90%
2017-10-04 only). 506.62K 4.90%
2017-09-19 Page 1 of 5 586.86K 5.70%
2017-07-11 Sabby Healthcare Master Fund, Ltd. 756.62K 4.46%
2017-06-08 2. 800K 7.70%
2017-06-08 2. 8M 7.70%
CLPT Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $13.68 28.32M $387.35M $45.92M $58.23M $399.66M
2024-12-31 $15.38 27.03M $415.69M $20.1M $3.57M $399.15M
2023-12-31 $6.79 24.61M $167.07M $23.14M $13.94M $157.87M
2022-12-31 $8.47 24.18M $204.82M $27.62M $11.99M $189.19M
2021-12-31 $11.22 20.73M $232.64M $54.11M $12.28M $190.81M
2020-12-31 $15.89 15.85M $251.85M $20.1M $24.12M $255.87M
2019-12-31 $4.80 13.16M $63.14M $5.7M $2.46M $59.91M
2018-12-31 $1.57 10.93M $17.16M $3.1M $3.48M $17.54M
2017-12-31 $2.75 7.74M $21.28M $9.29M $4.92M $16.91M
2016-12-31 $3.40 2.75M $9.37M $3.32M $4.49M $10.54M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-06-30 $17.84 29.86M $532.68M $29.36M $63.95M $567.26M
2026-03-31 $9.10 29.55M $268.88M $35.59M $63.59M $296.87M
2025-12-31 $13.68 28.32M $387.35M $45.92M $58.23M $399.66M
2025-09-30 $21.79 28.43M $619.44M $38.22M $35.74M $616.96M
2025-06-30 $11.94 28.26M $337.4M $41.54M $35.46M $331.32M
2025-03-31 $11.89 27.72M $329.58M $12.39M $3.44M $320.63M
2024-12-31 $15.38 27.03M $415.69M $20.1M $3.57M $399.15M
2024-09-30 $11.21 27.59M $309.3M $21.57M $3.69M $291.42M
2024-06-30 $5.33 27.47M $146.41M $32.84M $13.8M $127.36M
2024-03-31 $6.73 25.45M $171.29M $35.35M $13.9M $149.84M
2023-12-31 $6.79 24.63M $167.22M $23.14M $13.94M $158.03M
2023-09-30 $5.01 24.63M $123.4M $24.34M $14.01M $113.07M